林华医疗 (835637.OC)

+ 收藏

利润表(林华医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 452,756,457.94941,831,467.38434,608,734.16814,720,997.99375,476,694.73
 营业收入(元) 452,756,457.94941,831,467.38434,608,734.16814,720,997.99375,476,694.73
二、营业总成本(元) 347,629,647.61697,484,206.57336,592,765.23616,866,295.88282,256,910.05
 营业成本(元) 144,195,236.30289,116,697.76128,201,410.59232,937,385.98112,531,863.85
 研发费用(元) 18,120,878.1644,983,072.9020,356,472.2847,835,832.7519,932,130.10
 营业税金及附加(元) 7,535,484.2114,384,327.166,835,857.2212,647,406.026,064,488.32
 销售费用(元) 121,889,832.63250,593,174.13131,929,906.00217,409,911.07103,697,187.43
 管理费用(元) 58,601,939.44101,567,323.5250,914,555.28110,976,377.1043,204,285.27
 财务费用(元) -2,713,723.13-3,160,388.90-1,645,436.14-4,940,617.04-3,173,044.92
  其中:利息费用(元) 21,467.74116,591.03131,342.19102,979.5054,107.48
  其中:利息收入(元) 2,677,589.093,213,349.461,394,146.162,354,376.641,168,630.23
三、其他经营收益
 加:公允价值变动收益(元) -86,328.7798,065.7676,931.50-182,767.12148,602.74
 加:投资收益(元) 596,962.973,308,003.011,369,939.774,138,744.421,982,539.68
 资产处置收益(元) 19,917.19-88,408.40109,843.65-2,629,684.32107,241.13
 资产减值损失(元) -50,759.01-943,607.57-28,140.49-1,434,292.14-17,838.47
 信用减值损失(元) -272,411.93-133,189.39-182,574.52-60,711.50-36,213.53
 其他收益(元) 12,510,065.1715,157,302.595,285,735.4111,455,633.627,397,305.96
四、营业利润(元) 117,844,255.95261,745,426.81104,647,704.25209,141,625.07102,801,422.19
 加:营业外收入(元) 203,283.37491,871.03151,912.18391,289.25139,263.78
 减:营业外支出(元) 376,392.429,328,525.28594,258.20403,818.94346,996.22
五、利润总额(元) 117,671,146.90252,908,772.56104,205,358.23209,129,095.38102,593,689.75
 减:所得税费用(元) 20,050,970.3339,105,394.2715,891,039.9224,883,603.9018,060,464.88
六、净利润(元) 97,620,176.57213,803,378.2988,314,318.31184,245,491.4884,533,224.87
  其中:被合并方在合并前实现利润(元) ----8,534,775.51-
(一)按经营持续性分类
  持续经营净利润(元) 97,620,176.57213,803,378.2988,314,318.31184,245,491.4884,533,224.87
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 98,094,822.97214,834,267.9388,363,896.07184,245,229.4584,533,224.87
  少数股东损益(元) -474,646.40-1,030,889.64-49,577.76262.03-
 扣除非经常性损益后的净利润(元) 87,883,216.23207,196,258.7083,390,467.48182,821,528.0377,115,622.72
七、每股收益
 一、基本每股收益(元) 0.270.600.250.510.23
 二、稀释每股收益(元) 0.270.600.250.510.23
八、其他综合收益(元) -205,050.00-215,325.00-
 归属于母公司股东的其他综合收益(元) -205,050.00-215,325.00-
九、综合收益总额(元) 97,620,176.57214,008,428.2988,314,318.31184,460,816.4884,533,224.87
 归属于母公司所有者的综合收益总额(元) 98,094,822.97215,039,317.9388,363,896.07184,460,554.4584,533,224.87
 归属于少数股东的综合收益总额(元) -474,646.40-1,030,889.64-49,577.76262.03-
公告日期 2024-08-282024-04-252023-08-242023-04-252022-08-24
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院